Clinical Pharmacologists Back Drug Advert Ban
Clinical Pharmacologists Back Drug Advert Ban
We strongly endorse the proposal for a DTCA ban and the establishment of an independent consumer drug information service. Clinical Pharmacologists are specialists in the science, evaluation and appropriate utilisation of drugs.
We are concerned that New Zealand consumers have not been adequately informed of the limitations, inappropriateness and commercial bias inherent in most direct-to-consumer advertising (DTCA). There is good evidence that DTCA is counterproductive as it provides selective information for consumers and so reduces the effectiveness of prescribers to ensure that their patients are appropriately informed.
Our group is particularly concerned about the monitoring of DTCA, as many of the claims are gross exaggerations.
There is a universal recognition of the need for high quality medicines information for both health professionals and consumers. We believe this should be provided independently from the drug manufacturers. The information should be scientifically valid, up-to-date, reasonably comprehensive and readily understandable. Safety information is essential, but frequently underplayed in DTCA.
DTCA is only permitted in
two countries, the USA and NZ. Other countries do not see it
as appropriate. It is time for the public of NZ to have
access to unbiased drug
information.
Stats NZ: Economic Impacts On New Zealand From Conflict In The Middle East – Report
Advertising Standards Authority: ASA Annual Report 2025 - Platform-Neutral Regulation Keeps Pace With Digital Advertising
Science Media Centre: Lead Pipes Banned For New Plumbing – Expert Reaction
New Zealand Young Physicists Trust: Auckland To Host The ‘World Cup Of Physics’ In 2027; Search Begins For Student-Designed Tournament Logo
Oxfam Aotearoa: Top CEO Pay Increased 20 Times Faster Than Workers’ Pay In 2025
Bill Bennett: TUANZ Report - Networks Built, Value Missing

